PLUS1
22.05
0.32 (1.47%)
0.32 (1.47%)
Upgrade to Real-Time
Afterhours
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Protagonist Therapeutics Inc | PTGX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.32 | 1.47% | 22.05 | 16:02:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 21.73 | 21.60 | 22.60 | 22.05 | 21.73 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.01 | 23.20 | 23.19 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,670 | 185,095 | $ 22.24 | $ 4,116,908 | 321,874 | 4.47 - 24.02 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:28 | 14 | $ 22.05 | USD |
Protagonist Therapeutics Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 843.56M | 38.26M | 37.62M | $ 231.00k | $ - | -2.99 | -10.20 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Protagonist Therapeutics News
| Date | Time | Source | News Article |
|---|---|---|---|
| 11/11/2020 | 16:30 | PR Newswire (US) | Protagonist Therapeutics to Participate in the Jefferies.. |
| 11/04/2020 | 17:22 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/04/2020 | 17:13 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/04/2020 | 16:54 | PR Newswire (US) | Protagonist Therapeutics Reports Third Quarter Financial.. |
| 11/04/2020 | 10:20 | PR Newswire (US) | Protagonist Therapeutics to Present Updated Clinical Data.. |
| 10/30/2020 | 18:27 | PR Newswire (US) | Protagonist Therapeutics Reports Granting of Inducement.. |
| 10/29/2020 | 16:30 | PR Newswire (US) | Protagonist Therapeutics Announces Advancement of Oral IL-23.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PTGX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 22.56 | 23.75 | 20.30 | 21.96 | 557,726 | -0.51 | -2.26% |
| 1 Month | 19.82 | 24.02 | 17.44 | 21.41 | 344,539 | 2.23 | 11.25% |
| 3 Months | 22.40 | 24.02 | 17.44 | 21.19 | 356,360 | -0.35 | -1.56% |
| 6 Months | 16.40 | 24.02 | 14.16 | 18.98 | 379,469 | 5.65 | 34.45% |
| 1 Year | 9.46 | 24.02 | 4.47 | 13.76 | 570,584 | 12.59 | 133.09% |
| 3 Years | 19.33 | 24.02 | 4.47 | 12.61 | 323,673 | 2.72 | 14.07% |
| 5 Years | 12.00 | 26.3598 | 4.47 | 12.84 | 252,204 | 10.05 | 83.75% |
Protagonist Therapeutics Description
| Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidate to address medical needs. |
